Inventor · disambiguated record
Dragan Cicic
Also filed as: CICIC DRAGAN
5 granted patents·1 pending application·7 citations·filing 2017–2024
72Inventor score
Files withACTINIUM PHARMACEUTICALS INC6
Top patents by PatentIndex Score
6 records- 0190US11844799B2Method for treating cancer using a BCL-2 inhibitor in conjunction with an alpha-emitting radioimmunotherapeuticACTINIUM PHARMACEUTICALS INC·Filed 2022·Granted Dec 19, 2023·2 cites·2 claims
- 0286US11364235B2Method for treating cancer using a BCL-2 inhibitor in conjunction with an alpha-emitting radioimmunotherapeuticACTINIUM PHARMACEUTICALS INC·Filed 2018·Granted Jun 21, 2022·4 cites·18 claims
- 0382US12133849B2Method for treating cancer using a BCL-2 inhibitor in conjunction with an alpha- emitting radioimmunotherapeuticACTINIUM PHARMACEUTICALS INC·Filed 2023·Granted Nov 5, 2024·0 cites·7 claims
- 0481US2025017919A1Method for treating cancer using a bcl-2 inhibitor in conjunction with an alpha-emitting radioimmunotherapeuticACTINIUM PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0577US11292835B2Low dose antibody-based methods for treating hematologic malignanciesACTINIUM PHARMACEUTICALS INC·Filed 2017·Granted Apr 5, 2022·1 cites·6 claims
- 0668US12410249B2Low dose antibody-based methods for treating hematologic malignanciesACTINIUM PHARMACEUTICALS INC·Filed 2022·Granted Sep 9, 2025·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Dragan Cicic files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →